Elamipretide

Is Elamipretide FDA-approved?

Approved by the FDA. A licensed clinician has to decide it is right for you and prescribe it. Forzinity is FDA-approved for Barth syndrome under specialist care. Online SS-31 products remain unapproved.

As of September 28, 2026.

What does the evidence say about Elamipretide?

Clinical evidence supports a narrow rare-disease indication, not general longevity, energy or wellness use.

What are the risks and side effects of Elamipretide?

• The approved indication is narrow and does not include anti-aging.
• Injection-site reactions and hypersensitivity require clinical oversight.
• Rare-disease approval does not validate RUO copies.
• Long-term use outside the approved population has not been established.

What should you ask a clinician about Elamipretide?

• Does any evidence apply to my condition rather than Barth syndrome?
• How can I distinguish Forzinity from an RUO SS-31 vial?

These save with the compound when you add it to My Journal, so they’re on the printout for your visit.

Where can I get Elamipretide?

1 provider list Elamipretide on DiscoverMedica, lowest listed price first.

† Prices as listed by the provider when we checked; they change.

Sources

• DailyMed: Forzinity prescribing information
• FDA: Accelerated approval of Forzinity for Barth syndrome

Educational information only, not medical advice. It does not replace a conversation with a licensed clinician.